CoChat

Depressive disorders in HIV/AIDS:A clinically focused narrative review

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Abstract

Learning objectives: After participating in this activity, learners should be better able to: • Assess strategies for diagnosing depressive disorders in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) • Identify factors that contribute to the development of depressive disorders in HIV/AIDS • Evaluate strategies for managing depressive disorders in HIV/AIDS Depressive disorders and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are associated with major socioeconomic burdens. The negative impact of depressive disorders on HIV/AIDS is well known, including on treatment outcomes. Unfortunately, depressive disorders are underdiagnosed and undertreated in seropositive persons. This review summarizes clinically useful information on depressive disorders in HIV/AIDS. More specifically, we address assessment, differential diagnosis, contributing factors, management, and common challenges in the treatment of depressive disorders in seropositive individuals. Assessment and diagnosis of depression may be challenging in seropositive persons because of several biopsychosocial particularities associated with HIV/AIDS. One of the difficulties is the overlap between depression and HIV/AIDS symptoms, particularly in individuals with advanced AIDS, requiring consideration of a broad differential diagnosis. Several factors related to HIV/AIDS status contribute to the higher rates of depressive disorders, including infectious-immunological, psychosocial, and exogenous factors. The treatment of depressive disorders in HIV/AIDS involves three groups of interventions: (1) pharmacological interventions, (2) psychotherapeutic interventions, and (3) management of other contributing factors. Challenges in management include poor adherence to treatment and the risk of suicide. We provide evidence-based recommendations to improve assessment and management of depressive disorders in seropositive persons.

Overview

Integrity signals

Registry

Crossref · 10.1097/hrp.0000000000000252

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 113 references

Research works printed but not linked: 4

  1. 2018, Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis, AIDS, 32, S5
  2. 2012, Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review, AIDS, 26, S117
  3. 2015, Cognitive impairment in patients with AIDS—prevalence and severity, HIV AIDS (Auckl), 7, 35
  4. 2008, Choosing antidepressants for HIV and AIDS patients: insights on safety and side effects, Psychiatry (Edgmont), 5, 61

Cited by

See all 19

Metadata

Authors
Medeiros, G. C., Smith, F. A., Trivedi, M. H., & Beach, S. R.
Affiliations
Harvard University (US)
Corresponding author
Medeiros, Gustavo C.
Venue
Harvard Review of Psychiatry
Published
2020-04-07
Volume
28
Issue
3
Pages
146-158
ISSN
  • 1067-3229 (ISSN-L)
  • 1465-7309
OpenAlex
W3014811130
Cited by
19
References
113
Citations by year
2026: 3 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 3
FWCI
0.11
Type
journal article
Language
en
Open access
closed
Locations
  • Harvard Review of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
depressive disorders, HIV/AIDS, depression diagnosis, differential diagnosis, risk factors for depression, pharmacotherapy, psychotherapeutic interventions, medication adherence, suicide risk, psychosocial factors, biopsychosocial factors
MeSH terms
Suicide Prevention, Acquired Immunodeficiency Syndrome, Antidepressive Agents, Depressive Disorder, Diagnosis, Differential, HIV Seropositivity, Humans, Psychotherapy, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Depressive disorders in HIV/AIDS:A clinically focused narrative review. https://app.cochat.ai/papers/10.1097/hrp.0000000000000252
The paper
Medeiros, G. C., Smith, F. A., Trivedi, M. H., & Beach, S. R. (2020). Depressive disorders in HIV/AIDS:A clinically focused narrative review. Harvard Review of Psychiatry. https://doi.org/10.1097/hrp.0000000000000252

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.